Award of a contract to an independent scientific institution to accompany and evaluate the testing of high-flow therapy for chronic obstructive pulmonary disease (COPD) and chronic respiratory insufficiency

Lot 1: Testing of high-flow therapy for chronic obstructive pulmonary disease (COPD) and chronic respiratory insufficiency type 1.

Lot 2: Testing of high-flow therapy for chronic obstructive pulmonary disease (COPD) and chronic respiratory failure type 2.

The trial is intended to answer the question of whether HFT in patients with COPD and chronic respiratory insufficiency type 1 can be used in addition to

Long-term oxygen therapy (LTOT) compared to LTOT alone

is superior to health-related quality of life after 12 months.

The trial is intended to answer the question of whether HFT is present in patients with advanced COPD and chronic respiratory failure type 2.

compared to noninvasive ventilation in terms of health-related quality of life after 12 months.